Human immunodeficiency virus type 1 (HIV-1) envelope glycoproteins interact with CD4 and chemokine receptors on T cells to deliver signals that trigger either activation, anergy, or apoptosis. However, the molecular mechanisms driving these responses remain poorly understood. In this study we demonstrate that apoptosis is induced upon HIV-1 envelope binding to the chemokine receptor CXCR4. Cells expressing a mutant form of CXCR4 with a C-terminal deletion were also sensitive to HIV-1 envelope-mediated apoptosis, indicating that the cytoplasmic tail of CXCR4 is not required to induce the apoptotic pathway. The specificity of this process was analyzed using several inhibitors of gp120-CD4-CXCR4 interaction. Monoclonal antibodies directed against the gp120-binding site on CD4 (ST4) and against CXCR4 (MAB173) prevented the apoptotic signal in a dose-dependent manner. The cell death program was also inhibited by SDF-1␣, the natural ligand of CXCR4, and by suramin, a G protein inhibitor that binds with a high affinity to the V3 loop of HIV-1 gp120 envelope protein. These results highlight the role played by gp120-binding on CXCR4 to trigger programmed cell death. Next, we investigated the intracellular signal involved in gp120-induced apoptosis. This cell death program was insensitive to pertussis toxin and did not involve activation of the stress-and apoptosis-related MAP kinases p38 MAPK and SAPK/JNK but was inhibited by a broad spectrum caspase inhibitor (z-VAD.fmk) and a relatively selective inhibitor of caspase 3 (z-DEVD.fmk). Altogether, our results demonstrate that HIV induces a caspase-dependent apoptotic signaling pathway through CXCR4.
INTRODUCTION
HIV-1 gains entry into susceptible cells through the fusion of viral envelope and cellular membrane. This process is driven by HIV-1 envelope glycoprotein complexes formed by association of gp120 env and gp41 env . For most HIV isolates, fusion is preceded by a high-affinity interaction between HIV-1 gp120 env and the extracellular domain 1 of host cell surface CD4, a 58-kDa transmembrane glycoprotein expressed predominantly at the plasma membrane of mature peripheral T helper lymphocytes and macrophages Klatzmann et al., 1984; Littman, 1987; Sattentau et al., 1989) . The second step of molecular events leading to fusion is the triggering of conformational changes in the viral spikes (Jones et al., 1998; Lapham et al., 1996; Ugolini et al., 1997) . The resulting increased exposure of the gp120 env V3 loop allows it to interact with members of the seventransmembrane (TM)-domain chemokine receptor family, such as CXCR4 and CCR5, which act as coreceptors for T-tropic (X4) and M-tropic (R5) strains, respectively (Alkhatib et al., 1996; Feng et al., 1996) . Such interactions are thought to expose the hydrophobic fusion domain of the transmembrane envelope protein gp41 env , leading to viral entry (Weissenhorn et al., 1997) .
The misappropriation of CD4 and chemokine receptor function by HIV-1 likely has important consequences on cell homeostasis and virus propagation. Indeed, both CD4 and chemokine receptors initiate intracellular signaling upon their activation by natural ligands. Stromal cell-derived factor (SDF-1␣), the only known natural ligand of CXCR4, activates extracellular signal-regulated kinase (ERK), phosphatidyl-inositol 3Ј-kinase (PI-3K), and the transcription factor NF-kB and increases phosphorylation of focal adhesion components in cells transfected with CXCR4 (Ganju et al., 1998) . During the past few years, a large body of data has indicated that engagement of the cell surface CD4 molecule by HIV-1 gp120 env activates signal transduction pathways, such as that involving ERK, which in turn regulates transcription factors like NF-kB, AP1, and Elk1 (Alkhatib et al., 1996; Benkirane et al., 1994 Benkirane et al., , 1995 Briant et al., 1996 Briant et al., , 1998 Chirmule et al., 1994; Feng et al., 1996; Popik and Pitha, 1996; Schmid-Antomarchi et al., 1996) .
Since the discovery of seven-TM chemokine receptors as HIV coreceptors, several laboratories have investigated the possibility that HIV triggers intracellular signal-ing through these coreceptors. However, only the protein tyrosine kinase Pyk2 was shown to be phosphorylated after HIV-1 envelope binding to CXCR4 HIV-1 coreceptor on T cell lines through a signal transmitted by G␣i proteins (Davis et al., 1997) .
In parallel to these activation signals, which probably maximize the production of viral progeny, HIV-1 infection is characterized by a progressive drop of CD4 ϩ T lymphocytes (Fauci, 1993) . Both direct and indirect mechanisms of cytopathogenicity have been postulated to cause this cell depletion (Golding et al., 1988; Imberti et al., 1991; Lifson et al., 1986; Sodroski et al., 1986; Somasundaran and Robinson, 1987; Stevenson et al., 1988; Zinkernagel and Hengartner, 1994) . HIV-1-induced apoptosis has been proposed as one of the indirect mechanisms (Ameisen and Capron, 1991; Groux et al., 1992; Laurent-Crawford et al., 1991; Martin et al., 1994; Meyaard et al., 1992; Oyaizu et al., 1993; Terai et al., 1991) that act independently of syncytia formation (Connor et al., 1993; Corbeil and Richman, 1995; Maldarelli et al., 1995; Nardelli et al., 1995) .
Infectious X4 isolates of HIV-1-induced apoptosis in human T cell lines in which the cytoplasmic tail of CD4 was missing (Guillerm et al., 1998; Jacotot et al., 1997) . This suggested that the death program is not triggered by the CD4 molecule but may involve another HIV receptor. Considering the function of CXCR4 in signal transduction, we and others (Guillerm et al., 1998; Jacotot et al., 1997) postulated that the CXCR4 molecule may contribute to HIV-induced apoptosis. Recently, Hesselgesser et al. (1998) demonstrated that HIV-1 envelope glycoproteins induce apoptosis through CXCR4 in neuronal cells that do not express CD4. Moreover, Herbein and coworkers (Herbein et al., 1998) reported that apoptosis of CD8 ϩ T cells was triggered through interaction of HIV-1 gp120 env with CXCR4 and contacts between membranebound tumor-necrosis factor (TNF)-␣ on macrophages and TNF receptor II on CD8 ϩ cells. The aim of this study was to analyze the signaling specifically induced through CXCR4 after gp120 contact independently of the biological events triggered via CD4. For this purpose, we constructed a cell model using the HEK cell line cotransfected with CXCR4 and a mutated form of CD4 lacking the cytoplasmic domain which is incapable of activating a signal on its own. We found that HEK cell lines coexpressing this truncated form of CD4 and the CXCR4 molecule, either wild type or truncated after Ala308, were sensitive to HIV-1-induced apoptosis. Our results indicate that while CD4 is necessary for HIV-1 gp120 env binding to CXCR4, cell death requires expression of CXCR4 on the target cells. The CXCR4 C-terminal deletion mutant was still active, thus ruling out this domain in apoptotic signaling. Remarkably, apoptosis was dependent on caspases but did not involve G␣i or PI-3K, as it was not inhibited by pertussis toxin or wortmannin. Furthermore gp120 env binding to CXCR4 did not induce p38 MAPK or stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) activation, which has been coupled to apoptosis in other systems (Paul et al., 1997) . Although these observations need to be confirmed in more physiological situations (e.g., CXCR4 positive T cells), it is clearly established in this cellular model that HIV-1 triggers a caspase-dependent apoptosis through CXCR4.
RESULTS

Cellular model
To study the role specifically played by CXCR4 in HIV-1 envelope-induced apoptosis, HEK cells were transfected with the CD4.403 truncated form of CD4, which binds gp120 env but is unable to activate a signal on its own, or CD4.403 along with different forms of CXCR4. Clones were selected for surface expression of the transfected gene products and cocultured with 8.E5 cells which express HIV-1 gp120 env molecules at their surface. The heterologous HEK cell model system was chosen for several reasons: (i) the parental cell line lacks surface expression of both CD4 and CXCR4 (see below), (ii) this is a cellular model extensively used for the study of G protein-coupled receptor (GPCR)-mediated signals, (iii) this line has been successfully used in many apoptosis studies (Brustugun et al., 1998; Ozawa et al., 1999; Tenneti et al., 1997) , and (iv) CXCR4-transfected HEK cells have already proven useful for signaling and HIV-1 coreceptor function studies (Lee et al., 1998; Ling et al., 1999; Wang et al., 1998) . It is worth noting that HEK cells do not express the CCR5 gene. Moreover, transfected CXCR4 behaves as the natural molecule in HEK cells, since it supports HIV-1 coreceptor function and transduces signals upon engagement with SDF-1␣ (see below).
The following stable clones have been constructed for this study: (i) HEK/CD4.403 cells that express a truncated form of CD4 lacking the cytoplasmic domain, (ii) HEK/ CXCR4 cells expressing the wild type CXCR4, (iii) HEK/ CXCR4.7TM cells that express a truncated form of CXCR4 lacking the last cytoplasmic domain, (iv) HEK/ CD4.403/CXCR4 cells expressing the CD4 truncated form CD4.403 and the wild type CXCR4, and (v) HEK/ CD4.403/CXCR4.7TM cells expressing the truncated forms of CD4 and CXCR4. Cell surface expression of recombinant molecules was measured by flow cytometry (Fig. 1 ). Significant expression of CD4.403 and/or CXCR4 was found in the appropriate clones, and the selected clones show nearly identical levels of receptor expression. We note that CD4.403 is expressed at higher levels than CXCR4.
The physiological relevance of our cellular model was tested in several ways. First, we examined the capability of transfected CXCR4 to serve as a coreceptor for entry of an X4 isolate of HIV-1 (Lai strain). Four days after infection, the HIV-1 p24 gag protein was measured in HEK, HEK/CD4.403, and HEK/CD4.403/CXCR4 cells. High amounts of virus particles were detected only in doubly transfected cells, indicating that transfected CXCR4 allows efficient HIV-1 entry ( Fig. 2A) . Second, we analyzed the capability of transfected CXCR4 to transduce a signal in HEK/CD4.403/CXCR4 cells using SDF-1␣, the natural ligand of CXCR4. SDF-1␣ is known to induce tyrosine phosphorylation of the protein tyrosine kinase Pyk2 and to activate the ERK signaling pathway in T cells through CXCR4. As HEK cells exhibit low expression levels of endogenous Pyk2 (Della Rocca et al., 1997; Xiong and Parsons, 1997) , a large amount (500 g) of protein from the cell lysate was used to perform this assay. Under such experimental conditions, Pyk2 phosphorylation was detected after treatment of HEK/CD4.403/CXCR4 cells with PMA-Ionomycin and SDF-1␣. In contrast, RANTES, a ligand of CCR5 HIV-1 coreceptor, did not trigger Pyk2 phosphorylation, indicating that the signal observed was specific (Fig. 2B) . We also demonstrated in Fig. 2C that SDF-1␣ activates ERK in HEK/CD4.403/CXCR4 cells.
Altogether, our results corroborate previous observations by others (Lee et al., 1998; Wang et al., 1998) , indicating that this model of CXCR4-transfected cells is appropriate for studying signal transduction events induced by binding of CXCR4 natural ligand, SDF-1␣. Since we found CXCR4 expressed on HEK cells to serve as coreceptor for HIV-1 entry, this model should be also appropriated to investigate signals triggered by HIV-1 envelope binding to CXCR4.
Role of CXCR4 in HIV-1 induction of syncytia
It is generally accepted that HIV-1-induced syncytia formation involves interactions between HIV-1 gp120 env and CD4 (Sodroski et al., 1986 small syncytia were found after coculture of HEK/ CD4.403 with 8.E5 cells (Fig. 4, left) . No syncytia were observed when cells expressing CXCR4 alone were in contact with 8.E5 cells. This result indicates that syncytia formation not only requires HIV-1 gp120 env -CD4 interaction but also HIV-1 envelope proteins to bind the extracytoplasmic domains of CXCR4. Suramin, a compound that binds with a high affinity to the V3 loop of HIV-1 gp120 env (Fantini et al., 1997) , completely inhibited syncytia formation (Fig. 4, right) . Similarly, the monoclonal antibodies MAB173 and ST4 at 100 and 50 g/ml, respectively, inhibit syncytia formation (data not shown).
Role of CXCR4 in HIV-1-induced apoptosis
Apoptosis was studied in HEK cells expressing CD4.403 and different forms of CXCR4 after coculture with 8.E5 cells. Since DNA fragmentation is one hallmark of apoptosis, we analyzed the chromatin breakdown process using either staining of nuclei with the fluorescent dye Hoechst or double-stranded DNA break detection by incorporation of biotin-labeled deoxynucleotides on the 3Ј-OH termini (TUNEL assay). First, time course experiment indicated that apoptosis was induced in doubly transfected HEK cells by coculture with 8.E5 cells for 3 days and the highest percentage of apoptotic cells was observed after 4 days of coculture. No apoptosis was observed when doubly transfected cells were exposed to iHIV. To verify that apoptosis was specifically induced by a viral gene product, similar experiments were performed with the parental uninfected CEM cells, and no apoptosis was found (Fig. 5A ). To eliminate a putative role of soluble factors such as Tat, HEK/CD4.403/CXCR4 cells were incubated with the supernatant of 8.E5 cells cultured to a high density; this culture supernatant did not induce apoptosis (data not shown). Next, the different transfected or untransfected HEK cells were cocultured with 8.E5 cells for 4 days. 8.E5 cells triggered apoptosis in HEK/CD4.403/CXCR4 and HEK/CD4.403/CXCR4.7TM but not in singly transfected cell clones or untransfected HEK cells (Fig. 5B ), indicating that both CD4 and CXCR4 are required for HIV-1-induced apoptosis. Under these experimental conditions, CEM cells (Fig. 5B ) or iHIV (data not shown) did not trigger significant apoptosis in either transfected or untransfected HEK cells. Representative photographs are shown in Fig. 6 . This programmed cell death was inhibited in a dose-dependent manner by an anti-CXCR4 mAb (MAB173) and by the mAb ST4, directed against the gp120-binding site on CD4 (Fig. 7A) . At the same concentrations, isotype controls did not show any apoptosis inhibition (data not shown). Inhibition of programmed cell death by MAB173 and ST4 in HEK/ CD4.403/CXCR4 and HEK/CD4.403/CXCR4.7TM clones were similar. Furthermore, SDF-1␣ at 500 ng/ml inhibited 8.E5-induced apoptosis of doubly transfected HEK cells (Fig. 7B) . It is worth noting that SDF-1␣ alone did not induce apoptosis in our cellular system (data not shown). In addition, suramin, a G protein inhibitor (Beindl et al., 1996) that binds to the V3 loop of HIV-1 gp120 env (Fantini et al., 1997) , showed dose-dependent inhibition of apoptosis in HEK/CD4.403/CXCR4 and HEK/CD4.403/ CXCR4.7TM cells (Fig. 8A ). At 50 M suramin, the inhibition of 8.E5-induced apoptosis was complete, as measured by Hoechst staining (Fig. 8B ) and TUNEL assay (Fig. 8C) .
These results indicate that (i) cell surface expression of both exogenous CXCR4 and the extracellular domain of CD4 are needed to observe apoptosis in transfected HEK cells, (ii) the cytoplasmic tail of CXCR4 is not required, (iii) the viral glycoprotein involved is gp120 env , since apoptosis is inhibited by ligands of the gp120-binding site on CD4, of CXCR4, and of the gp120 env V3-loop, and (iv) gp120 env expressed at the cell surface, but not iHIV, triggers programmed cell death in doubly transfected HEK cells.
Search for mediators of CXCR4-driven apoptotic signaling
The envelope of X4 isolates of HIV-1 has previously been found able to activate Pyk2, a tyrosine kinase with multiple potential effector pathways. Among them are the stress pathways that include p38 MAPK and SAPK/JNK, as well as numerous pathways that target the transcription factors cAMP responsive element binding protein (CREB) and activating transcription factor 1 (ATF1). CREB phosphorylation on Ser 133 potentiates its ability to activate transcription, while the activation of the kinases SAPK/ JNK and p38 MAPK occurs via their phosphorylation on a Thr-Xaa-Tyr motif. Therefore their recognition by antibodies specific for the phosphorylated forms reflects their state of activation. Using immunoblotting, we investigated the putative consequences of HIV-1 envelope binding to CXCR4 on p38 MAPK , JNK, and CREB activation. To this end, we studied the phosphorylation of these molecules after HEK/CD4.403 and HEK/CD4.403/CXCR4 cells had been cocultured with 8.E5 cells. We found that MAPK , SAPK/JNK and CREB were not activated under these experimental conditions (Fig. 9A) . In contrast, phosphorylation was induced by PMA/ionomycin and anisomycin. Interestingly, phosphorylation of ATF1 was decreased in HEK transfected with CD4.403 and CXCR4, relative to CD4.403 transfected cells. Since Pyk2 phosphorylation induced after binding of HIV-1 envelope to CD4 ϩ cells was sensitive to pertussis toxin (PTX) treatment (Davis et al., 1997) , we also investigated the ability of this toxin to inhibit HIV-1 gp120 env -induced apoptosis. PTX at 500 ng/ml, a concentration previously shown to completely inhibit the calcium mobilization induced by SDF-1␣ in transfected adherent cells expressing CXCR4 , did not affect HIV-1 gp120 envinduced apoptosis (Fig. 9B) . Previous studies demonstrated that PI-3K and its metabolic products play an important role in signaling pathways related to chemotaxis (Carpenter and Cantley, 1996) and that PI-3K was activated after SDF-1␣ binding to CXCR4 (Ganju et al., 1998) . Accordingly, the PI-3K inhibitor wortmannin was found to partially inhibit SDF1-␣-induced cell migration (Ganju et al., 1998) . In our cellular model, wortmannin at 100 nM did not inhibit cell surface-expressed gp120 envinduced apoptosis, excluding a role for PI-3K (Fig. 9B) . Interestingly, the broad spectrum caspase inhibitor z-VAD.fmk inhibited this programmed cell death, indicating that caspases are implicated in this apoptotic pathway (Fig. 9B) . To better understand which caspases are involved in this process, we used more specific caspase inhibitor peptides at various concentrations: z-YVAD.fmk, which inhibits caspases 1 and 4, and z-DEVD.fmk, an inhibitor of caspases 3, 6, 7, 8, and 10. First, these caspase inhibitors were added at a 50 M concentration in Fas-and etoposide-treated transfected HEK cell culture to control their efficiency at inhibiting apoptosis induced by these reagents. z-VAD.fmk, z-DEVD.fmk, and z-YVAD.fmk blocked Fas-induced apoptosis, whereas only z-VAD.fmk was able to inhibit etoposide-mediated apoptosis (Fig. 9C) . Each caspase inhibitor was also added at different concentrations in this cellular system. z-VAD.fmk (50 M), 25 M z-YVAD.fmk, and z-DEVD.fmk completely blocked apoptosis of transfected HEK cells induced by the anti-Fas antibody (clone CH11). Interestingly, 25 M z-VAD.fmk did not inhibit etoposide-mediated apoptosis, while this concentration was still able to strongly inhibit (64.6%) CH11-induced HEK cell death (data not shown). Next, the ability of caspase inhibitors to prevent gp120 env -induced apoptosis of transfected HEK cells was studied. Doubly transfected HEK cell apoptosis was inhibited by z-VAD.fmk and z-DEVD.fmk at concentrations of 50 and 100 M, while z-YVAD. fmk inhibits very weakly at 100 M (Fig. 9D) .
Although gp120 env binding to CXCR4 induces neither the p38 MAPK nor the SAPK/JNK, engagement of HIV-1 gp120 env with CXCR4 triggers a death program that involves caspases, probably one of the caspase 3-like proteases.
DISCUSSION
The aim of this study was to investigate HIV-1-induced apoptosis through CXCR4 in cells that express CD4 molecules capable of binding to gp120 env but unable to transduce a signal on its own. Chemokine receptors, as CD4, are cell surface molecules that play major roles in T-cell signal transduction and can also deliver signals after engagement with HIV-1, leading to T-cell activation or apoptosis. There is therefore a need for a better understanding of signal transduction pathways activated by HIV-1 to determine which pathways are induced through CD4 and which ones can be ascribed to G protein-coupled receptors. Moreover, it is of major importance to distinguish between pathways which trigger cell activation from those which lead to apoptosis. To dissect the signal specifically transducted by CXCR4 after gp120 binding, without any interference with the pathways activated through CD4, we used a model cell system in which the external part of the CD4 molecule is present to allow subsequent gp120 binding on CXCR4 but in which the cytoplasmic tail is absent to avoid the interaction with CD4 downstream signaling cascades.
The events subsequent to binding of the HIV-1 envelope glycoproteins to CD4 and chemokine coreceptors that lead to HIV-1-mediated syncytia formation are not completely understood. First, syncytia formation was shown to be dependent on the interaction between HIV-1 gp120 env on the surface of infected cells and the CD4 receptor molecule of uninfected cells (Dalgleish et al., 1984; McDougal et al., 1986; Sodroski et al., 1986) . Subsequent work demonstrated that HIV-1 entry also depends on the presence of specific chemokine receptors. Indeed, syncytia formation was inhibited by anti-CXCR4 monoclonal antibodies (Barbeau et al., 1998) and small molecules which downmodulate CXCR4 . We directly demonstrate that CXCR4 and the extracytoplasmic domain of CD4 are needed for the formation of multinucleated giant cells after contact with HIV-1 gp120 env . Nevertheless, we cannot exclude a role of other cell surface molecules in this HIV-1-mediated syncytia formation as previously postulated by others (Barbeau et al., 1998; Hioe et al., 1998) . There is also some controversy in determining the role played by syncytia in HIV-1-induced cell death. This point will be addressed later in this discussion.
We and several others have shown that while the cytoplasmic tail of CD4 is needed for signal transduction induced by the HIV-1 envelope leading to AP-1 and NF-kB activation, it is necessary neither for gp120 env binding nor for syncytia formation (Bedinger et al., 1988; Benkirane et al., 1994; Golding et al., 1993; Poulin et al., 1991; Tremblay et al., 1994) . Furthermore, cells expressing truncated forms of CD4 that lack the cytoplasmic domain (CD4.401, CD4.403) can still undergo apoptosis (Guillerm et al., 1998; Jacotot et al., 1997) , suggesting that another HIV receptor may be involved in this process. The present study demonstrates that CXCR4 is responsible for apoptosis induced by the gp120 envelope glycoprotein of X4 HIV-1 isolates and that this cell death is not dependent on syncytia formation. Although there is some controversy as to the conformation of gp120 env needed to induce cell death, membrane expression of HIV envelope glycoproteins seems necessary to trigger apoptosis in CD4 cells (Corbeil and Richman, 1995; Guillerm et al., 1998; Laurent-Crawford et al., 1993) . As a model system, we used 8.E5 cells, which express a significant number of HIV-1 gp120 env at their surface (without producing infectious virions), to induce apoptosis in CD4.403 and CXCR4-transfected HEK cells. In parallel, we analyzed the putative role of heat-inactivated HIV (iHIV) in inducing apoptosis.
Only the cells doubly transfected with CD4.403 and CXCR4 or CXCR4.7TM (HEK/CD4.403/CXCR4 and HEK/ CD4.403/CXCR4.7TM) underwent apoptosis when they are cocultured with 8.E5 cells. No apoptosis was found when these doubly transfected cells were incubated with recombinant gp120 env (data not shown) or iHIV, indicating that gp120 env needs to be expressed at the surface of cells to trigger apoptosis. The fact that virus-cell fusion or recombinant gp120 env is not able to induce apoptosis might suggest either that gp120 env conformation differs between infected cells and iHIV or that signal elicited by adhesion molecules involved in close cell-to-cell contacts could also play a role in apoptosis. Notably, the adhesion molecule ICAM-1 (Rizzuto and Sodroski, 1997) and glycosphingolipids (Hammache et al., 1999) were shown to contribute to cell fusion. Apoptotic doubly transfected CD4.403 and CXCR4 or CXCR4.7TM HEK cells were found both as single and multinucleated giant cells, indicating that syncytia formation is not essential for induction of apoptosis. Furthermore, cytochalasin B, a compound that induces depolymerization of actin filaments, does not inhibit apoptosis but neutralizes syncytia formation (V.R-H. and M.B-P., unpublished observation). This result is in accordance with a recent paper from J. Blanco and coworkers (Blanco et al., 1999) . Nevertheless, syncytia can be involved in virus propagation and thus in disease progression. Since HEK/CD4.403 cells alone did not lead to apoptosis, this indicates that CXCR4 is needed for activating this cell death program. The resistance of HEK/CXCR4 and HEK/CXCR4.7TM cells to apoptotic signals induced by 8.E5 cells also indicates the involvement of CD4 in the initiation of apoptosis. The fact that mAb ST4, directed against the gp120-binding site on CD4, is able to inhibit the apoptotic signal transduction confirms the involvement of CD4 in the death process. Since our model system was selected to avoid CD4 dependent signal transduction, the role played by CD4 probably consists only of increasing the affinity of gp120 env for CXCR4 and thus the number of gp120 env molecules able to bind CXCR4 (Lapham et al., 1996) . This result agrees with those found in other cellular systems, where CXCR4 was shown to transduce apoptotic signals (Herbein et al., 1998; . Interestingly, each cellular system studied, except neuronal cells, suggests that other surface molecules contribute somehow to HIV-1 envelope-induced apoptosis through CXCR4. Recently, Berndt and collaborators (1998) described that both CD4 and CXCR4 play a role in HIV-1 envelope-induced apoptosis of CD4 ϩ T cells and T cell lines (Herbein et al., 1998; Hesselgesser et al., 1998) . We demonstrate here that, in our heterologous cell system, the extracellular domain of CD4 is important but CD4 function is likely limited to allow conformational changes in HIV-1 gp120 env . Notably, the cytoplasmic domain of CXCR4 is dispensable for apoptosis. The 18 serine/threonine residues of this cytoplasmic domain, which represent potential targets for phosphorylation by G protein-coupled receptor kinases, second messenger-activated protein kinases, and PKC (Freedman and Lefkowitz, 1996) are thus not involved in this apoptotic pathway. This region of CXCR4 was also implicated in CXCR4 turnover. Indeed, deletion of the C-terminal part of CXCR4 did not affect HIV entry but prevented SDF-1-induced receptor downmodulation (Amara et al., 1997) . Nevertheless, Wang and coworkers demonstrated recently that HIV-1 gp120 env inhibits the monocyte response to chemokines through CD4-dependent CXCR4 downregulation and showed that the entire CD4 molecule is needed for the internalization of CXCR4 (Wang et al., 1998) . It was thus interesting to study the expression of CXCR4 at the surface of HEK/CD4.403/ CXCR4 and HEK/CD4.403/CXCR4.7TM cells that have been cocultured for 4 days with 8.E5 cells. Under these experimental conditions, we found no decrease in cell surface expression of CXCR4 wild type or CXCR4.7TM (V.R-H. and M.B-P., unpublished observation). This indicates that CXCR4 is unable to internalize upon HIV-1 gp120 env binding when CD4 is expressed with a truncated cytoplasmic tail. The lack of heterologous desensitization makes this a useful cellular model for studying CXCR4 signaling.
To support our findings that gp120 env expressed at the surface of 8.E5 cells can specifically induce apoptosis via CXCR4, we demonstrated that the neutralizing mAb MAB173 specific for CXCR4 is able to inhibit the apoptotic pathway in a dose-dependent manner. The same amount of antibody is necessary to neutralize this cell death and to inhibit the syncytia formation. This latter experiment allowed an estimation of the quantity of antibody required to saturate transfected CXCR4 on HEK cells under our experimental cell culture conditions. In the same way, SDF-1␣ at 500 ng/ml strongly reduced gp120 env -induced apoptosis. We also tested the effect of suramin as an inhibitor in our assay. This compound binds with a high affinity to the gp120 env V3 loop of the viral envelope and blocks HIV-1-induced fusion and entry into CD4-exponent cells. Suramin completely blocked syncytia formation and apoptosis induced by 8.E5 cells in HEK/CD4.403/CXCR4 and HEK/CD4.403/CXCR4.7TM cells independently of the expression level of HIV-1 coreceptors, most likely by inhibiting the binding of gp120 env on CXCR4. This would agree with a very recent study demonstrating that apoptosis of primary brain cultures is induced by HIV-1 envelope binding to CXCR4 (Ohagen et al., 1999) .
SDF-1 binding to CXCR4 activates the protein kinase ERK, an important mediator of signaling from the membrane to the nucleus for many proliferative agents. Nevertheless, our previous observations (Briant et al., 1998) and the results from others did not suggest an involvement of CXCR4 in signals that activate ERK following HIV binding to CD4 ϩ cells. Furthermore, in our cellular model, the ERK pathway inhibitor PD98059 did not block the apoptotic signaling (data not shown). It seemed more likely that the p38 MAPK and SAPK/JNK cascades might be involved in HIV-induced apoptosis, since these pathways have been linked to induction of cell death in other systems. These kinases were present in the transfected HEK cells and activated by phosphorylation induced by the stress anisomycin, as well as by PMA coupled with ionomycin. However, neither p38 MAPK nor SAPK/JNK were activated under conditions that led to apoptosis, which rules out their role as mediators downstream of the gp120 env /CXCR4 complex. In confirmation of this, the p38 MAPK -specific inhibitor SB203580 (at 10 M) did not inhibit apoptosis (M.B.-P., unpublished data). The same holds true for PI-3K, since the specific inhibitor wortmannin did not affect apoptosis even at high con-centrations. In agreement with these results, Popik and Pitha recently reported that rapid phosphorylation of the ERK activating kinase (MEK), ERK, SAPK/JNK, and p38 MAPK was not induced by binding of a CXCR4-tropic simian immunodeficiency virus to CD4 ϩ /CXCR4 ϩ cells, although gp120 env of an R5 isolate of HIV-1 can stimulate these pathways through CCR5. This demonstrates that these two coreceptors do not transduce equivalent signals. In contrast, SB203580 apparently attenuated gp120 env -induced neuronal apoptosis, indicating that some neurotoxic processes initiated by gp120 env possibly use p38 MAPK (Kaul and Lipton, 1999) . The transcription factors CREB and ATF1 are useful indicators for multiple intracellular signaling systems. It is well documented for CREB that activating phosphorylation can be mediated by various intracellular second messenger/kinase pathways, such as cAMP/protein kinase A, calcium/calmodulin-dependent kinases II and IV, growth factors/p90
Rsk2 , and stress/(mitogen-activated protein kinase)-activated kinases 2 and 3 (Ghosh and Greenberg, 1995; Ginty, 1997) . None of these appears to mediate the gp120 env /CXCR4 apoptotic signal, since CREB phosphorylation was not induced. In contrast, this signal led to a decrease in phosphorylation of ATF1, therefore indicating that gp120 env has induced some, still unidentified, intracellular signaling pathway possibly involved in apoptosis. Its role in the programmed cell death will be established only upon its characterization.
As the caspase family of cysteine proteases are important mediators of apoptosis, we analyzed the ability of caspase inhibitor peptides to block gp120 env -induced apoptosis. The programmed cell death was inhibited by z-VAD.fmk, indicating that an important stage of this apoptotic process involves caspases. Furthermore, z-DEVD.fmk protected cells from apoptosis, indicating that this process requires activation of caspase-3 (-like) proteases. On the other hand, caspase-1 was not involved in gp120 env -mediated apoptosis because z-YVAD. fmk failed to markedly inhibit this cell death program, whereas it blocks anti-Fas-induced apoptosis. Interestingly, caspase 3 activation also seems to be correlated with changes in G protein-coupled signaling through CXCR4 during HIV-1-associated dementia (Zheng et al., 1999) . Further investigation is needed to identify the transduction pathways that link CXCR4 to caspase activation and subsequent cell death.
Our CD4/CXCR4 transfected HEK cell model has allowed a fine dissection of signals transducted through (1 h, 3 h, or 5 h) indicated above the lanes. To control for inducibility, the cells were also treated with 50 ng/ml anisomycin or PMA/ionomycin as indicated. Cell lysates (15 g per lane) were electrophoresed on SDS-PAGE minigels, transferred to PVDF, and immunodetected with antibodies specific for the phosphorylated versions of the proteins shown at the left of each panel. A loading control was added using an anti-p38 CXCR4 itself following engagement with HIV-1 gp120 env and provides direct evidence that CXCR4 is involved in HIV-1 gp120 env -induced apoptosis. These data, however, have to be further confirmed in more physiological systems because signaling pathways in HEK cells are likely not identical to T cells. Nevertheless, very recently, we demonstrated that CXCR4 present on CD4 ϩ human T cell lines plays a major role in HIV-1-induced apoptosis of these cells when cocultured for 2-days with gp120 envexpressing adherent cells, indicating that CXCR4 is clearly involved in HIV-1 gp120 env -induced apoptosis of CD4 ϩ T cells (Biard-Piechaczyk et al., 1999) . This observation probably has important physiological consequences. HIV preference for CCR5 versus CXCR4 undergoes a characteristic change during the course of infection and disease progression; the decline in immune system function coincides with the appearance of more aggressive viruses that use CXCR4 as receptor (Connor et al., 1997; Unutmaz and Littman, 1997) . One hypothesis for the increased pathogenicity of X4 strains could be that, after infection with R5 strains, there is first a CD4/ CCR5-dependent cell activation to enhance the propagation of the virus, and the switch to CXCR4 coreceptor would correspond with the ability to trigger apoptotic signals and a rapid decline of CD4 ϩ T cells. Therefore, the activation or alteration of the signaling pathways induced by binding of HIV-1 to their receptor and/or coreceptor obviously will have important consequences for HIV-induced pathogenicity, a notion that bears further study.
MATERIALS AND METHODS
Antibodies and reagents
Anti-CD4 monoclonal antibodies (mAb) BL4 and ST4 were kindly provided by M. Hirn (Coulter-Immunotech, Marseille, France) and D. Carriere (Sanofi-Recherche, Montpellier, France), respectively. Anti-CXCR4 mAb (MAB173), RANTES and SDF-1␣ were purchased from R&D Systems (R&D Systems Europe, Ltd., Abingdon, UK). Anti-gp120 110.4 mAb was obtained from Genetic Systems. Anti-human Fas antibody (clone CH11) was purchased from Upstate Biotechnology (Euromedex, Souffelweyershem, France). Anti-Pyk2 mAb was purchased from TEBU (Le Perray en Yvelines, France). Culture supernatants of 4G10 and PY72 hybridoma were a kind gift from N. Taylor (IGMM, Montpellier). Peroxidasecoupled goat anti-mouse Ig NA 931 was purchased from Amersham (Les Ullis, France). FITC-labeled FabЈ2 goat anti-mouse (GAM) immunoglobulin (Ig) was purchased from Immunotech. Rabbit antibodies specific for phosphorylated, activated versions of ERK, SAPK/JNK, p38, and CREB and for unphosphorylated proteins ERK and p38 were obtained from New England Biolabs (Ozyme, Saint Quentin en Yvelines, France). Peroxidase-coupled goat anti-rabbit antiserum was purchased from SigmaAldrich (L'Isle D'Abeau Chesnes, France). Protein G-Sepharose was purchased from Pharmacia (Pharmacia Biotech, Saclay, France). Suramin was purchased from TEBU. Bordetella pertussis toxin (PTX) was purchased from Calbiochem (France Biochem, Meudon, France). Wortmannin and etoposide were purchased from Sigma-Aldrich, z-Val-Ala-Asp (OMe)-CH 2 F (z-VAD. fmk), z-Tyr-Val-Ala-Asp (OMe)-CH 2 F (z-YVAD.fmk), and z-Asp(OCH 3 )-Glu(OCH 3 )-Val-Asp(OMe)-CH 2 F (z-DEVD. fmk) were purchased from Calbiochem. Geneticin (G418) and Zeocin were purchased from Gibco-Life Technologies (Eragny, France) and Invitrogen (Abingdon, UK) respectively.
Oligonucleotides
Cloning oligonucleotides. CD4 oligonucleotide primers were 5ЈCD4 (5ЈTCG CCG GAA TTC TAC TGC TCA GCC CCT TCC TC-3Ј) and 3Ј403 (5Ј-CCG ATG CTC GAG TTA TGC TTG GCG CCT TCG GTG CC-3Ј). CXCR4 oligonucleotide primers were 5ЈFus BABE (5Ј-GTG CAC GAA TTC GGC TTA AGT GAC GCC GAG-3Ј), 3ЈFus (5Ј-CCG ATG GTC GAC TTA CTT GTC ATC GTC GTC CTT GTA GTC GCT GGA GTG AAA ACT TGA AGA-3Ј), and 3Ј7TM (5Ј-CCG ATG GTC GAC TTA CTT GTC ATC GTC GTC CTT GTA GTC GGC TCC AAG GAA AGC ATA GAG-3Ј). The two 3Ј primers used to amplify the CXCR4 gene contain the sequence of the Flag epitope.
Sequencing oligonucleotides. T7 oligonucleotide was provided with the sequencing kit. CD4.1 (5Ј-TAC ATC TGT GAA GTG GAG-3Ј), CD4.2 (5Ј-GAA AAG CTG ACG GGC AGT-3Ј), CD4.3 (5Ј-CCT AAG CTG ATG CTG AGC-3Ј), Fus1 (5Ј-ACT ATT CCC GAC TTC ATC-3Ј), Fus2 (5Ј-CAC antibody. Two major species of SAPK/JNK are detected, p46 and p54, while all p38 MAPK isoforms comigrate under these gel conditions. The phospho-Ser133 CREB antiserum also recognizes the transcription factor ATF1 because the peptide used to generate this serum spans a region highly conserved between these two proteins. AGT CAT CCT CAT CCT-3Ј), Fus seq (5Ј-CTG GTA CTT TGG GAA CTT C-3Ј).
All these oligonucleotides were purchased from Eurogentec (Seraing, Belgium).
CD4 and CXCR4 expression vectors
The CD4.403 DNA fragment was amplified by PCR using the 5ЈCD4/3Ј403 oligonucleotide primer pair and the retroviral vector pMV7 containing the full-length CD4 cDNA obtained from Q. Sattentau (CIML, Marseille). The CD4.403 PCR DNA fragment was cloned in the pcDNA3 expression vector (Invitrogen). The CXCR4 fragment was amplified by PCR using the 5ЈFus BABE/3ЈFus oligonucleotide primer pair and, as template, the pBABE. Fusin vector was obtained through the NIH AIDS Research and Reference Reagent Program from N. Landau (Aaron Diamond AIDS Research Center, The Rockefeller University). This fragment was cloned in the pcDNA3 Zeo expression vector (Invitrogen). The CXCR4.7TM PCR DNA fragment was amplified by PCR using the 5ЈFus BABE/ 3Ј7TM oligonucleotide primer pair, and was cloned in the pcDNA3 Zeo. Before use, all inserts were sequenced on an Applied Biosystems Model 373A automated sequencer, using Taq polymerase and dye terminator.
Cells
The CEM T cell line was provided from the American Type Culture Collection (Bethesda, MD). The 8.E5 cell line, a CEM-derived T cell line containing a single integrated copy of X4 HIV-1 was provided by F. Barré -Sinoussi (Institut Pasteur, Paris). Cells were cultured in RPMI 1640 medium supplemented with 1% penicillin-streptomycin (PS) antibiotic mixture, 1% Glutamax, and 10% fetal calf serum (FCS; Gibco-Life Technologies) to a density of 5 ϫ 10 5 cells/ml in a 5% CO 2 atmosphere. Human embryonic kidney (HEK-293) cell line transformed by sheared human adenovirus type 5 DNA was provided by P. Boulanger (Institut de Biologie, Montpellier) and maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 1% PS antibiotics, 1% Glutamax, and 10% FCS. HEK cells (10 7 ) were transfected with 20 g of pcDNA3 CD4.403, pcDNA3 Zeo CXCR4, or pcDNA3 Zeo CXCR4.7TM plasmid using the classical calcium phosphate precipitation procedure (Sambrook et al., 1989) . Clones able to grow in the presence of the selection agent (G418 or Zeocin) were tested by flow cytometry for surface expression of CD4 or the different forms of CXCR4. HEK cells stably transfected with the pcDNA Neo CD4.403 vector were supertransfected by a second vector using a similar strategy, in order to select cells coexpressing CD4.403 and different forms of CXCR4. Several clones of each type were selected.
Detection for HIV-1 infection
Cells (5 ϫ 10 5 ) were incubated for 2.5 h at 37°C with 100 l of HIV-1 (Lai strain; X4 isolate) at a concentration of 1000 ϫ 50% tissue culture infective dose (TCID 50 ) per ml. Thereafter, cells were washed five times and cultured in 24-microwell plates. The amount of HIV-1 produced was monitored 4 days after infection by measuring p24 gag protein with a commercial antigen capture ELISA assay (Coulter, Coultronics, Margency, France).
ERK phosphorylation induced after SDF-1␣-binding on CXCR4
Twenty-four hours before cell activation, HEK/ CD4.403/CXCR4 cells were cultured in medium with 0.5% FCS to lower the basal level of protein activation. Cells were stimulated with SDF-1␣ at 500 nM for 1 min at 37°C, washed twice in PBS containing sodium fluoride (NaF) 10 mM, sodium orthovanadate (Na 3 VO 4 ) 1 mM, ␤-glycerophosphate (␤GP) 20 mM, and p-nitrophenylphosphate (PNPP) 10 mM, and lysed in Tris-HCl 50 mM (pH 8), Triton X-100 1%, NaCl 100 mM, MgCl 2 1 mM, benzamidine 2 mM, leupeptine 2 g/ml, PMSF 150 M containing NaF, Na 3 VO 4 , ␤GP, and PNPP as above (Hipskind et al., 1994) . Cell lysates were electrophoresed in 10% SDS-PAGE and blotted to PVDF membranes (Millipore). Membranes were then blocked in Tris-buffered saline (TBS), 5% BSA, 0.05% Tween 20 for 1 h at 20°C. Blots were incubated overnight at 4°C with the primary antibody diluted 1/1000 in the blocking buffer. After 30 min of washing in six changes of TBS-Tween, the blots were incubated for 1 h at 20°C with peroxidase-coupled goat anti-rabbit antiserum diluted 1/2000 in TBS-5% milk-Tween. After further washing, the immune complexes were revealed by enhanced chemiluminescence (ECL, NEN) and autoradiographied.
Pyk2 phosphorylation induced by chemokines
HEK/CD4.403/CXCR4 cells were stimulated with phorbol myristate acetate (PMA) at 40 ng/ml and Ionomycin at 1 M for 15 min, RANTES or SDF-1␣ at 500 nM for 30 s, washed, and lysed. Each lysate containing 500 g of protein was precleared by incubation for 1 h with 50 l of protein G-Sepharose (Sigma). Pyk2 was immunoprecipitated from supernatants for 12 h incubation at 4°C with anti-Pyk2 mAb fixed on protein G-Sepharose. The beads were washed three times in lysis buffer, resuspended in an equal volume of SDS-PAGE sample buffer, and analyzed on SDS-PAGE (8% polyacrylamide) gels. After immunoblotting, the membrane was incubated with the two anti-phosphotyrosine (anti-PTyr) antibodies (4G10 and PY72 mAbs) for 2 h at 20°C. After three washings, the NA 931 mAb was incubated for 30 min at 20°C and the blot was revealed as previously described. After dehybridization, the blot was incubated with the anti-Pyk2 mAb at 2 g/ml for 2 h at 20°C, washed, and the peroxidase anti-mouse Ig diluted 1/3000 was then added for 30 min at 20°C. The blot was revealed as before.
Activation of p38, SAPK/JNK, and CREB after gp120-binding on CXCR4
After being cocultured with 8.E5 cells, transfectant HEK cells were washed and lysed as previously described. Cell lysates were electrophoresed in 10% SDS-PAGE and blotted to PVDF membranes. Blots were incubated overnight at 4°C with primary antibodies diluted 1/1000 in the blocking buffer. After washings, the blots were incubated for 1 h at 20°C with peroxidase-coupled goat anti-rabbit antiserum diluted 1/2000 and the immune complexes were revealed by enhanced chemiluminescence and autoradiographied.
Flow cytometry
Cells (1 ϫ 10 5 ) were incubated for 1 h at 4°C with 50 l of PBS containing 0.2% BSA (PBS-BSA) or PBS-BSA supplemented with the appropriate mAb at concentrations necessary for saturation of cell surface molecules. After three washes with PBS-BSA, bound mAb was revealed by addition of 50 l of a 1/50 dilution of fluorescein-conjugated (FITC) GAM Ig (Immunotech). After 30 min staining, cells were washed with PBS-BSA and fluorescence intensity at 543 nm was measured on an EPICS XL4-C cytofluorometer (Coulter, Coultronics, Margency, France).
Determination of syncytia formation
Transfected or untransfected HEK cells were cultured in the presence of 10 5 8.E5 cells for 4 days at 37°C in a 5% CO 2 atmosphere in the absence or in the presence of agents that may interfere with cell lysis. Syncytia formation was monitored by light microscopy.
Detection of apoptosis
Detection of HIV-1-induced apoptosis was monitored by nuclear condensation and DNA fragmentation. Apoptotic adherent cells cultured on slides in 24-well plates were visualized using either Hoechst staining (dye Hoechst 33258, Sigma) or an ApoDETEK kit (Enzo Diagnostics, Farmingdale, NY) for the terminal dUTP nick end-labeling (TUNEL) assay. Briefly, adherent cells were cocultured for 1 to 4 days with 10 5 8.E5 or CEM cells per ml. Then, adherent cells were extensively washed with complete medium to eliminate the T cells in suspension and fixed in 3.7% paraformaldehyde in PBS (pH 7.4) containing 0.1% Triton X-100 for 15 min at 20°C. After two washings with PBS, cells were incubated with either Hoechst solution (Sigma) at 0.2 g/ml for 30 min at 20°C or the terminal deoxynucleotide transferase and biotin-16-dUTP for 1 h at 37°C followed by incubation with PBS containing avidine-FITC for 30 min at 4°C. After two washings, slides were mounted using Mowiol solution and examined by epifluorescence. Monoclonal antibodies used as inhibitors were preincubated for 1 h with HEK transfected cells before adding 8.E5 cells. The percentage of living and apoptotic cells was recorded in more than 14 random fields containing less than 100 cells per field. The total number of counted cells per slide was always higher than 200 cells. Results are from at least four independent experiments. Apoptosis was also analyzed after incubation of transfected or untransfected HEK cells with heat-inactivated HIV-1 (iHIV) from Lai strain (an X4 isolate of HIV-1). iHIV solution corresponds to 1000 ϫ 50% tissue culture infective doses (TCID 50 ) of infectious virus per ml.
